HHS Unveils Ten Drugs Selected for Medicare Price Negotiation Program
- September 01, 2023
Merck & Co, Johnson & Johnson (J&J), and AstraZeneca are among the pharmaceutical manufacturers whose drugs were one of the ten selected for the first round of the new Medicare drug price negotiation program, according to the much-anticipated list unveiled by the Department of Health and Human Services (HHS) on August 29.
ARTICLE TAGS
You must be logged in to access this content.